Sanctus Bio Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 5.00 M
as on 12-12-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 M
as on 12-12-2024
- Revenue 7.86%
(FY 2022)
- Profit -101.38%
(FY 2022)
- Ebitda 65.94%
(FY 2022)
- Net Worth -47.65%
(FY 2022)
- Total Assets -9.07%
(FY 2022)
About Sanctus Bio
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Naga Nandury, Shivram Mantripragada, Ramesh Kamaraju, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900TG2015PTC097535
- Company No.
097535
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sanctus Bio?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Nandury  | Director | 05-Feb-2015 | Current |
| Shivram Mantripragada | Director | 05-Feb-2015 | Current |
| Ramesh Kamaraju | Whole-Time Director | 05-Feb-2015 | Current |
| Ramakrishna Varma | Whole-Time Director | 21-Jan-2016 | Current |
Financial Performance of Sanctus Bio.
Sanctus Bio Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.86% increase. The company also saw a substantial fall in profitability, with a 101.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 47.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanctus Bio?
In 2020, Sanctus Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Snam Vijaya Feeds LimitedActive 30 years 14 daysNaga Nandury and Shivram Mantripragada are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Feb 2016 | ₹8.00 M | Satisfied |
How Many Employees Work at Sanctus Bio?
Unlock and access historical data on people associated with Sanctus Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanctus Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanctus Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
